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Background: CD4
+Fop3
+ regulatory T cells (Tregs) are need-
ed to maintain peripheral tolerance, but their role in the de-
velopment of autoimmune arthritis is still debated. The pres-
ent study was undertaken to investigate the mechanism by 
which Tregs influence autoimmune arthritis, using a mouse 
model entitled K/BxN. Methods: We generated Treg-defi-
cient K/BxNsf mice by congenically crossing K/BxN mice 
with Foxp3 mutant scurfy mice. The arthritic symptoms of the 
mice were clinically and histopathologically examined. The 
proportions and activation of CD4
+ T cells and/or dendritic 
cells were assessed in the spleens, draining lymph nodes and 
synovial tissue of these mice. Results: K/BxNsf mice ex-
hibited earlier onset and more aggressive progression of ar-
thritis than their K/BxN littermates. In particular, bone de-
struction associated with the influx of numerous RANKL+ 
cells into synovia was very prominent. They also contained 
more memory phenotype CD4
+ T cells, more Th1 and Th2 
cells, and fewer Th17 cells than their control counterparts. 
Plasmacytoid dendritic cells expressing high levels of CD86 
and CD40 were elevated in the K/BxNsf synovia. 
Conclusion: We conclude that Tregs oppose the progression 
of arthritis by inhibiting the development of RANKL
＋ cells, 
homeostatically proliferating CD4
＋ T cells, Th1, Th2 and ma-
ture plasmacytoid dendritic cells, and by inhibiting their influx 
into joints.
[Immune Network 2011;11(5):299-306]
INTRODUCTION
CD4
＋Foxp3
＋ regulatory T cells (Tregs) make up 5∼10% of 
peripheral CD4
＋ T cells and are essential for maintaining pe-
ripheral  self-tolerance (1). The transcription  factor Foxp3 is 
not only a unique marker for Tregs but also is required for 
the development and activity of the Tregs. The importance 
of Tregs in preventing autoimmunity has been proven in scur-
fy  mice  and  in  human  patients  with  immunodysregulation, 
polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) 
(2,3).  Both  the  mice  and  human  mutants  lack  functional 
Tregs  due  to  loss-of-function  mutations  in  the  Foxp3  gene, 
and the absence of these cells is accompanied by severe auto-
immune responses affecting many organs. In addition, quanti-
tative and functional defects in Tregs are associated with auto-
immune disorders, such as type 1 diabetes, multiple sclerosis 
and  systemic  lupus  erythematosus  (4-6).
    Tregs elicit their regulatory effects on other immune cells 
by  diverse  mechanisms.  They  were  originally  identified  by 
finding that they  inhibited the proliferation  of other T cells 
as well  as cytokine production  by  the latter (7). They also 
regulate the maturation of dendritic cells (DCs), so preventing 
T  cell  priming  (8).  Their  suppressive  activity  depends  on 
cell-to-cell contact and/or the production of cytokines. Apart 
from secondary lymphoid tissues, Tregs are also found at sites 
of inflammation, such as arthritic synovial tissue and diabetic 
pancreases, although their roles such locations remain unclear Role of Regulatory T Cells in Arthritis
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(9,10). 
    Rheumatoid arthritis (RA) is a chronic inflammatory auto-
immune disease that is characterized by anarchic remodeling 
of joint architecture (11). Arthritogenic T cells and autoanti-
bodies  that  migrate  into  the  joints  elicit  inflammatory  re-
sponses and lead to progressive destruction of cartilage and 
bone. Although the cause of RA is poorly understood, it is 
thought to be due to an adaptive immune response to auto-
antigen  are  accompanied  by  an  inflammatory  response. 
    Several groups have attempted to identify the role of Tregs 
in the pathogenesis of RA. A study using a collagen-induced 
arthritis model showed that depletion of Tregs increased sus-
ceptibility to the disease, whereas the other study indicated 
that Tregs were not involved in controlling proteoglycan-in-
duced  arthritis  (12,13).  The  results  in  humans  have  been 
more diverse, since Tregs from patients with RA have been 
variously shown to be fully functional, partially defective, or 
fully defective (14-16). Therefore, the role of Tregs in RA is 
still  a  matter  of  debate.
  K/BxN is a murine model of RA that has many of the clin-
ical and histologic features of the human disease (17). In a 
previous study, we found that K/BxN mice contained normal 
number of Foxp3
＋ Tregs (18), and that these cells efficiently 
suppressed the proliferation of naïve CD4
＋ T cells, and cyto-
kine production by effector CD4
＋ T cells, in vitro. Despite 
the existence of functionally intact Tregs, K/BxN mice devel-
op autoimmune arthritis. This prompted us to investigate the 
role of Tregs in the pathogenesis of K/BxN arthritis. We gen-
erated  Treg-deficient  K/BxN  mice  (referred  to  as  K/BxNsf 
mice hereafter) and examined diverse aspects of arthritis in 
these  mice.  We  found  that  Treg  deficiency  in  K/BxN  mice 
resulted in earlier onset and more aggressive progression of 
arthritis, and that this coincided with increased activity of au-
toreactive T cells in secondary lymphoid organs and synovial 
tissue. Moreover, Treg deficiency increased the frequency and 
m a t u r i t y  o f  D C s  i n  t h e  i n f l a m e d  s y n o v i a .  T h u s ,  o u r  r e s u l t s 
suggest that although the activities of Tregs are not sufficient 
to block the development of arthritis in K/BxN mice, they re-
duce the severity of the autoimmune arthritis by lowering the 
activity of CD4
＋ T cells and DCs in secondary lymphoid or-
gans  and  synovia.
MATERIALS AND METHODS 
Mice 
KRN TCR transgenic mice on a C57BL/6 background (K/B) 
were donated by Dr. Diane Mathis (17), and maintained in 
our facility. A cross between K/B and NOD mice generated 
transgenic  progeny  (K/BxN)  and  non-transgenic  littermates 
(BxN).  Female  C57BL/6  mice  bearing  a  scurfy  (sf)  allele 
(Jackson Laboratory, Bar Harbor, ME, USA) were backcrossed 
to NOD for more than 6 generations to generate NODsf con-
genic mice. A cross between female NODsf mice and male 
K/B mice generated K/BxN and K/BxNsf mice. All mice were 
maintained  in  a  specific  pathogen-free  barrier  facility  at 
Hanyang University. The study was approved by institutional 
Animal  Care  and  Use  Committee.
Clinical and histopathologic evaluation of arthritis
The mice were inspected blind and disease severity was eval-
uated  using  a  scoring  system  as  previously  described  with 
modifications  (19):  0,  normal;  1,  slight  erythema  and  mild 
swelling confined to the mid-foot (tarsals) or ankle joint; 2, 
erythema and mild swelling extending from the ankle to the 
mid-foot; 3, erythema and moderate swelling extending from 
the ankle to the metatarsal joints; 4, intensive erythema and 
severe swelling encompassing the ankle, foot, and digits; 5, 
severe  ankylosis  of  the  ankle.  In  this  system,  the  maximal 
score per mouse is 20 and scores are expressed as the mean 
arthritic  index  on  a  given  day.  The  thickness  of  both  hind 
ankles was measured axially across the malleoli using a cali-
per (Mitutoyo, Kanagawa, Japan). Hind paws were removed 
postmortem, fixed, and decalcified in Rapid-Cal Immuno sol-
ution  (BBC,  Stanwood,  WA,  USA).  They  were  then  em-
bedded  in  paraffin,  sectioned,  and  stained  with  H&E. 
Flow cytometry 
Single-cell suspensions of spleen, lymph node (LN) cells and 
synovial cells were stained with monoclonal Abs (mAbs) as 
previously  described  (18).  The  f o l l o w i n g  m A b s  w e r e  p u r -
chased from BD Biosciences (San Jose, CA, USA): anti-B220 
(RA3-6B2), anti-CD4 (RM4-5), anti-IL-17 (TC11-18H10.1), an-
ti-CD11c (R2-40), anti-CD11b (TC11-18H10.1), anti-CD40 (TC11- 
18H10.1), anti-CD86 (TC11-18H10.1), anti-CD3 (TC11-18H10.1), 
anti-NK1.1 (TC11-18H10.1), and anti-γ δ TCR (B56). The fol-
l o w i n g  m A b s  w e r e  o b t a i n e d  f r om  eBioscience  (San  Diego, 
CA, USA): anti-CD80 (16-10A1), anti-CD25 (7D4), anti-Foxp3 
(FJK-16s), anti-IFN-γ (XMG1.2), and anti-IL-4 (BVD6-24G2). 
The mAbs conjugated with FITC, PE, PerCP, or allophycocya-
nin  were  used.Role of Regulatory T Cells in Arthritis
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Figure 1. Accereration and exercerbation of arthritis in K/BxNsf mice.
(A) Joint swelling in K/BxN and K/BxNsf mice was inspected blind. 
The ankle thickness of hind paws (left) and arthritic indices of all paws 
(right) are shown (n=6 mice/group). Data are means±SEM. *p<0.05, 
**p<0.01, and ***p<0.001 by Student’s t-test. (B) Hind paws from 
BxN, K/BxN, and K/BxNsf mice were examined by histopathologic 
methods. Representative photographs of each group are shown. 
Original magnification, ×40. (C) Hind paw sections were stained with
anti-RANK or RANKL Ab, followed by immunohistochemical 
processing. Original magnification, ×400.
Immunohistochemistry
Hind paw tissues were fixed, embedded in paraffin, and sec-
tioned at 7μm in thickness. Endogenous peroxidase was in-
activated by treatment with 3% H2O2 in absolute methanol. 
After  blocking  nonspecific  binding  with  normal  goat  serum 
in  PBS,  the  sections  were  incubated  with  rabbit  Ab  to  re-
ceptor activator of nuclear factor kappa-B (RANK; Santa Cruz 
Biotechnology, CA, USA) or RANK ligand (RANKL; Santa Cruz 
Biotechnology) at appropriate dilutions. The sections were in-
cubated  with  secondary  Ab  and  exposed  to  avidin-bio-
tin-peroxidase complexes and 3,3’-diaminobenzidine (Dako, 
Carpinteria, CA, USA). The sections were counterstained with 
hematoxylin,  and  the  samples  were  photographed  with  a 
photomicroscope  (Olympus,  NY,  USA).
Synovial cell extraction
S y n o v i a l  t i s s u e s  f r o m  i n f l a m e d  a n k l e  j o i n t s  o f  K / B x N  a n d  
K/BxNsf mice were minced using scissor and digested with 
0.5  mg/ml  of  Liberase  Blendzyme  II  (Roche  Diagnostics, 
Indianapolis, IN, USA) in plain RPMI 1640 medium for 45 min 
at  37
oC .  D i g e s t e d  t i s s u e  w a s  w a s h e d  t h r e e  t i m e s  i n  s t e r i l e  
plain RPMI and filtered through a cell strainer to collect single 
cell  suspension.
Proliferation assay
Mouse  glucose-6-phosphate  isomerase  peptide  (GPI282-294; 
LSIALHVGFDHFE)  was  produced  by  Peprotech  (Daejeon, 
Korea) (18). Splenocytes (10
5/well) from K/BxN or K/BxNsf 
mice were cultured in the presence of irradiated BxN spleno-
cytes (10
5/well) as APC and the indicated concentrations of 
GPI282-294.  After  pulsing  with 
3H-thymidine  (0.5μCi/well; 
Amersham  Biosciences,  Piscataway,  NJ,  USA)  for  the  last  9 
hours  of  a  total  of  72  hours  of  culture, 
3H-thymidine  in-
corporation  was  assayed.  All  assays  were  conducted  in 
triplicate.
RESULTS
Acceleration and exacerbation of arthritis in K/BxNsf 
mice
We found several differences between the arthritic symptoms 
o f  K / B x N s f  m i c e ,  l a c k i n g  T r e g s ,  a n d  t h e i r  T r e g - c o n t a i n i n g  
K/BxN littermates. The onset of arthritis occurred earlier and 
disease  progression  was  accelerated  in  K/BxNsf  mice  (Fig. 
1A). Ankle thickness, a measure of joint swelling, peaked 8 
days earlier in K/BxNsf mice than in K/BxN mice. Despite 
the earlier decline of ankle thickness, joint deformity as in-
dicated by arthritic indices and histological examination was 
much more severe in K/BxNsf mice than in the K/BxN mice 
up to 14 weeks of age (Fig. 1A and B). For example, the 
metatarsal bones were already invaded in the K/BxNsf mice 
at 4 weeks of age, while they were intact in K/BxN mice of 
the  same  age  (Fig.  1B). 
    RANKL is a member of the TNF ligand superfamily, which 
is expressed by activated T cells and osteoblasts (20). RANKL 
binding to its unique receptor RANK activates the formation Role of Regulatory T Cells in Arthritis
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Figure 2. Treg deficiency enhances autoreactive activation of CD4
+
T cells. (A) CD4
＋ T cell numbers in spleens and dLNs of K/BxN and 
K/BxNsf mice. *p<0.05, **p<0.01, and ***p<0.001 by Student’s
t-test. (B) Splenocytes purified from 4 week-old mice were cultured 
with irradiated splenocytes from BxN mice and GPI peptide at the
indicated concentrations for 72 hr. 
3H-thymidine was added during 
the last 9 h, followed by 3H-thymidine incorporation assays. Values 
represent mean±SD (C) Percentage of CD4
＋CD44
loCD62L
hi and
CD4
＋CD44
hiCD62L
lo cells in the spleens and dLNs of 5-10-week-old
BxN, K/BxN, and K/BXNsf mice. Histograms represent the percentage
of CD25
＋ cells among CD4
＋CD44
hiCD62L
lo cells. (D) Absolute 
numbers of naïve, memory and activated CD4
＋ T cells in spleens and
dLNs of K/BxN and K/BxNsf mice (n=7).
Figure 3. The profiles of Th1, Th2, and Th17 cells in the spleen and
dLNs of K/BxNsf mice. (A and B) Splenocytes and dLN cells from 5 
- 6 week-old BxN, K/BxN, and K/BxNsf mice were stimulated with 
PMA/ionomycin for 5 h and stained for CD4, IL-4, IFN-γ, and IL-17.
FACS profiles gated on CD4
＋ cells are shown. A representative result 
of three independent experiments with the percentage of cells in each
quadrant is shown. (C) Th1, Th2, and Th17 cell numbers in spleen 
and dLNs of K/BxN and K/BxNsf mice. 
and function of osteoclasts, leading to bone resorption and 
loss. We performed immunohistochemical analyses to detect 
RANKL- and RANK-expressing cells in the hind paw joints of 
6-week-old K/BxN and K/BxNsf mice. RANKL
＋ and RANK
＋ 
cells were much more abundant in the synovial tissues of the 
K/BxNsf  mice  than  in  those  of  the  K/BxN  mice  (Fig.  1C). 
Thus,  these  results  demonstrate  that  Tregs  play  a  role  in 
damping the severity of inflammation and bone destruction 
in  the  K/BxN  arthritic  model.
Treg deficiency enhances the quantity and activity 
of autoreactive CD4
＋ T cells
We examined whether Treg deficiency affected the number 
and/or  activity  of  arthritogenic  T  cells.  Total  CD4
＋ T  c e l l  
numbers  were  significantly  higher  in  the  spleens  and 
joint-draining LNs (dLNs) of 4-8 week-old K/BxNsf mice than 
i n  t h e i r  K / B x N  l i t t e r m a t e s  ( F i g .  2 A ) .  T h e s e  c e l l s  m u l t i p l i e d  
more than those from K/BxN mice even in the absence of 
exogenous  GPI282-294  peptide,  displaying  enhanced  self  re-
a c t i v i t y  a g a i n s t  e n d o g e n o u s  G P I  p e p t i d e  ( F i g .  2 B ) .  
    We have shown previously that K/BxN mice contain nu-
merous  homeostatically  proliferating  CD4
＋ T  c e l l s  r e t a i n i n g 
memory-like  phenotypes,  and  that  these  cells  are  distinct 
from conventionally activated cells. Consistent with this, the 
large  majority  of  CD4
＋ T  c e l l s  p o p u l a t i n g  the  spleens  and 
dLNs  of  K/BxN  mice  had  memory  (CD44
hiCD62L
loCD25
−) 
phenotypes, while a few had undergone conventional activa-
tion (CD44
hiCD62L
loCD25
＋) or remained naïve (CD44
loCD62L
hi) 
(Fig. 2C). The most prominent characteristic of the K/BxNsf 
mice  was  an  increased  frequency  and  absolute  number  of 
memory  phenotype  CD4
＋  cells  in  their  spleens  and  dLNs 
(Fig. 2C and D). There were no comparable increase in con-
ventionally activated CD4
＋ T cells in K/BxNsf mice (Fig. 2D). 
    To determine whether Treg deficiency affects the develop-
ment of effector helper T (Th) cells, we assessed the profiles 
of IFNγ-, IL-4-, or IL-17-producing Th1, Th2 and Th17 cells, 
respectively,  in  the  spleen  and  dLNs  of  BxN,  K/BxN  and 
K/BxNsf  mice.  The  K/BxNsf  mice  contained  significantly 
more  Th1  and  Th2  cells  in  their  spleens  and  dLNs  than 
K/BxN mice (Fig. 3A and C), while the proportion of Th17 
cells was lower than in K/BxN mice, even though there was 
no difference in the absolute number of Th17 cells. Immuno-Role of Regulatory T Cells in Arthritis
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Figure 4. The profiles of synovial T cells from K/BxNsf mice. (A) 
Synovial cells extracted from ankle joints of 5 week-old BxN, K/BxN,
and K/BxNsf mice were stained with mAbs to CD4 and Foxp3 and
assayed by FACS. Representative FACS profiles gated on live 
lymphocytes are shown. (B) Synovial cells were stimulated with 
PMA/ionomycin for 5 h, followed by intracellular cytokine staining 
for CD4, IL-4, and IFN-γ. FACS profiles gated on CD4
＋ cells are 
shown. (C) Synovial cells were stimulated with PMA/ionomycin for 
5 h and stained for IL-17, CD4, CD3, NK1.1, and γ δ TCR. One 
representative result of three independent experiments with the 
percentages of cells in each gate is shown.
fluorescence  staining  confirmed  the  existence  of  effector  T 
cells in the spleens of K/BxN and K/BxNsf mice, especially 
in the extrafollicular areas but not in the follicular areas (Data 
not  shown).
    Thus our results show that Treg deficiency results in dra-
matic  expansion  of  memory  phenotype  CD4
＋  T  cells,  pre-
sumably homeostatically proliferating T cells, in response to 
endogenous GPI self antigen. Treg deficiency also results in 
population of T cell zone by Th1 and Th2 cells but not Th17 
cells. The latters seem not to be involved in the germinal cen-
ter  reaction. 
Treg deficiency alters the cellularity of inflamed 
synovium
We examined whether Treg deficiency affects synovial cellu-
larity in the K/BxN mice. To this end, we first tested whether 
Tregs are present in the synovial tissue of K/BxN mice. While 
T r e g s  w e r e  n o t  s e e n  i n  s y n o v i a l  t i s s u e  i n  t h e  s t e a d y  s t a t e ,  
in the inflamed synovial tissue of K/BxN mice approximately 
40%  of  the  CD4
＋ T  c e l l s  w e r e  F o x p 3
＋  Tregs  (Fig.  4A). 
Therefore, we suspected that Tregs play a substantial role in 
the  pathology  of  the  synovia. 
  T o  d e t e r m i n e  w h e t h e r  t h e  a b s e n c e  o f  T r e g s  a f f e c t s  t h e  
homing of effector T cells to inflamed synovial, we examined 
the profiles of  synovial T cells in K/BxNsf mice.  As in the 
secondary lymphoid organs, K/BxNsf synovia contained more 
IFNγ
＋ Th1 cells and IL-4
＋ Th2 cells and fewer IL-17
＋ cells 
than K/BxN synovia (Fig. 4B). Since IL-17 can be produced 
by NK T cells and γδ T cells in addition to Th17 cells, we 
further  characterized  the  phenotype  of  the  IL-17-producing 
synovial cells. The majority of these cells in the arthritic joints 
expressed  CD3  and  γδ TCR,  while  few  if  any  expressed 
CD4 or NK1.1 (Fig. 4C). Taken together, these results dem-
onstrate that a deficiency of Tregs facilitates the influx of Th1 
and Th2 cells into arthritic joints and does not affect the fre-
quency  of  IL-17-expressing  synovial  γδ T  cells.
Identification and characterization of DC subsets in 
synovial cells from K/BxNsf mice
    Two major subsets of DCs, myeloid DCs (mDCs) and plas-
macytoid DCs (pDCs), are abundant in the synovial fluid and 
perivascular regions of synovial tissues from patients with RA, 
suggesting  that  these  DCs  play  an  important  role  in 
inflammation. Hence, we tested whether Treg deficiency af-
fected the DC subsets in the inflamed synovia. To this end, 
s y n o v i a l  c e l l s  e x t r a c t e d  f r o m  arthritic  joints  of  K/BxN  and 
K/BxNsf mice were stained for CD11c, CD11b and B220. The 
proportion of CD11c
＋CD11b
−B220
＋ pDCs was significantly 
higher and of CD11c
＋CD11b
＋B220
− mDCs was slightly low-
er in K/BxNsf synovia than in K/BxN synovia (Fig. 5A). In 
addition, the expression levels of CD40 and CD86 were high-
er in the K/BxNsf pDCs than in those from K/BxN mice (Fig. 
5B). The difference with regard to CD80 did not reach stat-
istical significance. However, no upregulation of these mole-
cules  was  seen  in  the  mDCs  of  K/BxNsf  mice  (Data  not 
shown). Thus, these results demonstrate that Treg deficiency 
leads to the accumulation of pDCs with higher costimulatory 
capacities  in  inflamed  synovia.
DISCUSSION
Despite the existence of functionally intact Foxp3
＋ Tregs in 
K/BxN mice, these mice spontaneously develop arthritis. We Role of Regulatory T Cells in Arthritis
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Figure 5. Enrichment of mature pDCs in the synovium of K/BxNsf 
mice. (A) Synovial cells extracted from ankle joints of 5 week-old BxN,
K/BxN, and K/BxNsf mice were stained with mAbs to CD11b, CD11c,
and B220. CD11c
＋CD11b
＋ cells (small circle) and CD11c
＋CD11b
−
cells (large circle) were gated for mDC and pDC, respectively. 
Histograms show the expression of B220 among each gate. Most 
CD11c+CD11b- pDC express B220 but most CD11c
＋CD11b
＋ mDC 
are B220 negative. The bar graphs on the right panel show the 
frequency of mDC or pDC on live lymphocyte gate. (B) The 
maturation status of CD11c
＋CD11b
−B220
＋ pDCs was assessed by 
mean fluorescence intensity (MFI) of the co-stimulatory molecules 
CD40, CD80 and CD86. Bars and numbers indicate the mean of three
animals. p-values in plots were calculated by Student’s t-test.
were  therefore  prompted  to  consider  the  role  of  Tregs  in 
these mice. We found that K/BxNsf mice lacking Tregs ex-
hibited more serious symptoms of arthritis than their K/BxN 
littermates, including more extensive bone destruction, asso-
ciated  with  increased  proportion  of  RANKL
＋ c e l l s  i n  t h e i r  
synovial. They also contained more memory phenotype CD4
＋ 
T cells in their secondary lymphoid organs and synovia--- pre-
sumably  proliferating  homeostatically  in  response  to  auto-
antigens--- as well as more Th1 and Th2 cells. Importantly, 
pDCs with more mature phenotypes were more frequent in 
the synovia of the K/BxNsf mice than in those of the K/BxN 
mice. Thus, these results suggest that Tregs exert their effects 
on arthritogenic T cells and DCs, and so reduce the severity 
of  disease.
    We found that Treg deficiency resulted in general activa-
tion of T cells with the exception of Th17 cells. Unlike Th1 
and Th2 cells, Th17 cells were more frequent in the K/BxN 
mice than the K/BxNsf mice. This result is intriguing in the 
light  of  the  developmental  and  functional  antagonism  be-
tween Tregs and Th17 cells. We suspect that it may be due 
to the enrichment of Th1 and Th2 cells. Given that Th1 and 
Th2 cells can suppress the development of Th17 cells (21), 
such suppression may prevail over the direct effect of Treg 
deficiency. In addition, this result implies that Th17 cells do 
not play an important role in the exacerbation of arthritis in 
this model. Indeed, we observed that γδ T cells were more 
significant  producers  of  IL-17  than  Th17  cells.
  We found above that Tregs, which are barely detected in 
synovia at steady state, became very numerous in inflamed 
synovia. This observation is in line with other reports show-
ing enrichment of Tregs in inflamed tissues such as the syno-
vial fluid of RA patients, pancreatic islets, colitis lesions, and 
the skin in graft-versus-host disease (22-25). This finding sug-
gests that locally inflamed tissue provides a niche for Tregs 
to play a role in tissue-topical inflammatory responses. In this 
context,  it  would  be  of  interest  to  further  characterize  the 
phenotypes  and  activities  of  synovial  Tregs  compared  with 
those  in  secondary  lymphoid  organs. 
    An intriguing change in the Treg-deficient synovia was the 
increase  in  pDCs  expressing  elevated  levels  of  CD40  and 
CD86. In agreement of this observation, others have detected 
the accumulation of pDCs in disease lesions in animal models 
and patients with autoimmune diseases, including type 1 dia-
betes, multiple sclerosis, Sjögren’s syndrome and RA (26-29). 
Moreover,  activated  pDCs  in  local  tissues  preferentially  se-
crete chemokines such as CXCL9, CXCL10, CCL3, CCL4 and 
CCL5, which can attract autoreactive T cells, so aggravating 
the disease (30-32). Similarly, we found that K/BxNsf synovia 
contained  more  Th1,  Th2,  and  RANKL
＋  cells  than  K/BxN 
synovia. Therefore, we propose that synovial DCs are targets 
for  the  Treg  activity  that  reduces  synovial  inflammation.
    In conclusion, we have shown that Tregs reduce the se-
verity of autoimmune arthritis by suppressing the activities of 
T cells and DCs in secondary lymphoid organs and synovial 
tissue. 
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